Piperacillin
Spécifications
61477-96-1Numéro CAS
262-811-8Numéro CE
(2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acidNom IUPAC
C23H27N5O7SFormule chimique
517.6 g/molMasse molaire
piperacillin; 61477-96-1; Piperacillin anhydrous; Piperacilline; Piperacilina; Peracin; Piperacillina; Piperacillinum; PIPC; CHEBI:8232; Pipercillin; (2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 9I628532GX; DTXSID2023482; AB Piperacillin; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-6-(((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)phenylacetyl)amino)-7-oxo-, (2S-(2-alpha,5-alpha,6-beta(S*)))-; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta(S*)))-; (2S,5R,6R)-6-[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinecarboxamido)-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid monohydrate; Pipera hameln; (2S,5R,6R)-6-(((2R)-2-(((4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl)amino)-2-phenylacetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; (2S,5R,6R)-6-(((2R)-2-((4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino)-2-phenylacetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; (2S,5R,6R)-6-((2R)-2-(((4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl)amino)-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; Piperacillin curasan; Curasan, Piperacillin; Piperacillin ratiopharm; RefChem:929312; DTXCID303482; J01CA12; 262-811-8; X00B0D5O0E; Piperacillin [INN]; Piperacillin hydrate; MFCD00865043; Piperacillin (INN); CHEMBL702; PIPERACILLIN, ANHYDROUS; (2S,5R,6R)-6-((R)-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[(2R)-[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]phenylacetyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)-; (2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)amino]-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6beta-{(2R)-2-[(4-ethyl-2,3-dioxopiperazin-1-yl)carboxamido]-2-phenylacetamido}-2,2-dimethylpenam-3alpha-carboxylic acid; Peperacillin; Pipracil, Piper; Peracin (TN); CCRIS 7362; EINECS 262-811-8; Piperacilina [INN-Spanish]; Piperacilline [INN-French]; Piperacillinum [INN-Latin]; Piperacillin?; UNII-9I628532GX; Piperacillin CRS; WPP; Prestwick0_000755; Prestwick1_000755; Prestwick2_000755; Prestwick3_000755; PIPERACILLIN [MI]; PIPERACILLIN [JAN]; Epitope ID:116652; 6-(D-(-)-alpha-(4-Ethyl-2,3-dioxo-1-piperazinecarboxamido)phenylacetamido)penicillanic acid; SCHEMBL33894; BSPBio_000770; PIPERACILLIN [MART.]; (2S-(2alpha,5alpha,6beta(S*)))-6-(((((4-Ethyl-2,3-dioxopiperazin-1-yl)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; BIDD:GT0167; PIPERACILLIN [WHO-DD]; SPBio_002709; BPBio1_000848; orb1219943; GTPL10921; MSK5644; GLXC-22993; HMS2090H19; HY-B1923; Tazocin (piperacillin + tazobactam); BDBM50240426; EBC-12090; AKOS016007827; DB00319; FE27060; NCGC00484859-01; (2S,5R,6R)-6-[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; AS-13671; SY240046; CS-0013978; NS00009682; P3462; D08380; AB01275515-01; EN300-6733491; F858773; Q423787; BRD-K86873305-236-03-0; BRD-K86873305-236-14-7; BRD-K86873305-236-15-4; BRD-K86873305-236-16-2; Z2587996977; (2S,5R,6R)-6-((R)-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid; (2S,5R,6R)-6-{[(2R)-2-(4-Ethyl-2,3-dioxopiperazine-1-carboxamido)-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[(2R)-[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]phenylacetyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)-; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[(2R)-2-[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)-; Piperacillin monohydrateSynonymes
Produits contenant Piperacillin
타박신주4.5그램(피페라실린나트륨.타조박탐나트륨)타박신주2.25그램(피페라실린나트륨.타조박탐나트륨)タゾピペ配合点滴静注用バッグ2.25「DSEP」/タゾピペ配合点滴静注用バッグ4.5「DSEP」ゾシン配合点滴静注用バッグ4.5タゾピペ配合静注用2.25「SN」/タゾピペ配合静注用4.5「SN」タゾピペ配合静注用2.25「DSEP」/タゾピペ配合静注用4.5「DSEP」タゾピペ配合静注用2.25「明治」/タゾピペ配合静注用4.5「明治」タゾピペ配合静注用2.25「ニプロ」/タゾピペ配合静注用4.5「ニプロ」/タゾピペ配合点滴静注用バッグ2.25「ニプロ」/タゾピペ配合点滴静注用バッグ4.5「ニプロ」ゾシン静注用2.25/ゾシン静注用4.5PIPERACILINA/TAZOBACTAM TILLOMED 4 G/0,5 G POLVO PARA SOLUCIÓN PARA PERFUSIÓN EFGPIPERACILINA/TAZOBACTAM TILLOMED 2 G/0,25 G POLVO PARA SOLUCIÓN PARA PERFUSIÓN EFGPIPERACILINA/TAZOBACTAM KABI 4 g/0,5 g POLVO PARA SOLUCION PARA PERFUSION EFG
Page 1 sur 7
Entreprises vendant Piperacillin
AP
Aurobindo Pharma LimitedIndiaPage 1 sur 4